Despite the evidence linking anti-TNF strategies with the improvement of insulin sensitivity, it is not known how the selective neutralization of solTNF signaling can impact the deleterious metabolic-immune interactions present in obesity that affects IR [17, 18]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.